Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women. [electronic resource]
Producer: 20101215Description: 759-63 p. digitalISSN:- 1128-3602
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Biomarkers -- blood
- Biphenyl Compounds -- therapeutic use
- Blood Glucose -- metabolism
- Blood Pressure -- drug effects
- Body Mass Index
- Body Weight
- Cholesterol -- blood
- Cytokines -- blood
- Female
- Humans
- Hypertension -- blood
- Imidazoles -- therapeutic use
- Insulin -- blood
- Irbesartan
- Middle Aged
- Nicotinamide Phosphoribosyltransferase -- blood
- Obesity -- blood
- Prospective Studies
- Spain
- Tetrazoles -- therapeutic use
- Time Factors
- Treatment Outcome
- Triglycerides -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.